Dalal Street Investments
Top

Ranbaxy, IVRCL Approvals

May 21, 2007

Ranbaxy Laboratories has received approval from Canadian authorities to sell Ran-Pravastatin, a cholesterol lowering drug, in Canada.

IVRCL Infrastructures & Projects has bagged irrigation projects worth Rs 551 crore from Andhra Pradesh Government.

Comments

Got something to say?






Bottom